Literature DB >> 24482062

Role of T-type channels in vasomotor function: team player or chameleon?

Ivana Y-T Kuo1, Lauren Howitt, Shaun L Sandow, Alexandra McFarlane, Pernille B Hansen, Caryl E Hill.   

Abstract

Low-voltage-activated T-type calcium channels play an important role in regulating cellular excitability and are implicated in conditions, such as epilepsy and neuropathic pain. T-type channels, especially Cav3.1 and Cav3.2, are also expressed in the vasculature, although patch clamp studies of isolated vascular smooth muscle cells have in general failed to demonstrate these low-voltage-activated calcium currents. By contrast, the channels which are blocked by T-type channel antagonists are high-voltage activated but distinguishable from their L-type counterparts by their T-type biophysical properties and small negative shifts in activation and inactivation voltages. These changes in T-channel properties may result from vascular-specific expression of splice variants of Cav3 genes, particularly in exon 25/26 of the III-IV linker region. Recent physiological studies suggest that T-type channels make a small contribution to vascular tone at low intraluminal pressures, although the relevance of this contribution is unclear. By contrast, these channels play a larger role in vascular tone of small arterioles, which would be expected to function at lower intra-vascular pressures. Upregulation of T-type channel function following decrease in nitric oxide bioavailability and increase in oxidative stress, which occurs during cardiovascular disease, suggests that a more important role could be played by these channels in pathophysiological situations. The ability of T-type channels to be rapidly recruited to the plasma membrane, coupled with their subtype-specific localisation in signalling microdomains where they could modulate the function of calcium-dependent ion channels and pathways, provides a mechanism for rapid up- and downregulation of vasoconstriction. Future investigation into the molecules which govern these changes may illuminate novel targets for the treatment of conditions such as therapy-resistant hypertension and vasospasm.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24482062     DOI: 10.1007/s00424-013-1430-x

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  96 in total

Review 1.  T-type calcium channels and vascular function: the new kid on the block?

Authors:  Ivana Y-T Kuo; Stephanie E Wölfle; Caryl E Hill
Journal:  J Physiol       Date:  2010-12-20       Impact factor: 5.182

2.  Insulin-mediated upregulation of T-type Ca2+ currents in GH3 cells is mediated by increased endosomal recycling and incorporation of surface membrane Cav3.1 channels.

Authors:  Alicia Toledo; Alejandro Sandoval; Ricardo González-Ramírez; Traudy Ávila; Angélica Almanza; Eduardo Monjaraz; Juan Carlos Gomora; Erika S Piedras-Rentería; Ricardo Felix
Journal:  Cell Calcium       Date:  2012-07-07       Impact factor: 6.817

Review 3.  Modulation of low-voltage-activated T-type Ca²⁺ channels.

Authors:  Yuan Zhang; Xinghong Jiang; Terrance P Snutch; Jin Tao
Journal:  Biochim Biophys Acta       Date:  2012-09-10

Review 4.  Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels.

Authors:  P B L Hansen
Journal:  Acta Physiol (Oxf)       Date:  2013-02-21       Impact factor: 6.311

5.  Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart.

Authors:  L L Cribbs; B L Martin; E A Schroder; B B Keller; B P Delisle; J Satin
Journal:  Circ Res       Date:  2001-03-02       Impact factor: 17.367

6.  p47(phox) is required for afferent arteriolar contractile responses to angiotensin II and perfusion pressure in mice.

Authors:  En Yin Lai; Glenn Solis; Zaiming Luo; Mattias Carlstrom; Kathryn Sandberg; Steven Holland; Anton Wellstein; William J Welch; Christopher S Wilcox
Journal:  Hypertension       Date:  2011-12-19       Impact factor: 10.190

Review 7.  Low threshold T-type calcium channels as targets for novel epilepsy treatments.

Authors:  Kim L Powell; Stuart M Cain; Terrance P Snutch; Terence J O'Brien
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

8.  ATP-sensitive K+ channel activation by calcitonin gene-related peptide and protein kinase A in pig coronary arterial smooth muscle.

Authors:  G C Wellman; J M Quayle; N B Standen
Journal:  J Physiol       Date:  1998-02-15       Impact factor: 5.182

9.  Voltage-gated calcium channel currents in human coronary myocytes. Regulation by cyclic GMP and nitric oxide.

Authors:  J F Quignard; J M Frapier; M C Harricane; B Albat; J Nargeot; S Richard
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

10.  Spreading vasodilatation in the murine microcirculation: attenuation by oxidative stress-induced change in electromechanical coupling.

Authors:  Lauren Howitt; Daniel J Chaston; Shaun L Sandow; Klaus I Matthaei; Frank R Edwards; Caryl E Hill
Journal:  J Physiol       Date:  2013-02-25       Impact factor: 5.182

View more
  12 in total

Review 1.  Cardiac ion channels.

Authors:  Birgit T Priest; Jeff S McDermott
Journal:  Channels (Austin)       Date:  2015-08-20       Impact factor: 2.581

2.  Age-dependent impact of CaV 3.2 T-type calcium channel deletion on myogenic tone and flow-mediated vasodilatation in small arteries.

Authors:  Miriam F Mikkelsen; Karl Björling; Lars Jørn Jensen
Journal:  J Physiol       Date:  2016-02-18       Impact factor: 5.182

Review 3.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 4.  Relevance of tissue specific subunit expression in channelopathies.

Authors:  Hartwig Seitter; Alexandra Koschak
Journal:  Neuropharmacology       Date:  2017-06-29       Impact factor: 5.250

5.  Nox1 upregulates the function of vascular T-type calcium channels following chronic nitric oxide deficit.

Authors:  Lauren Howitt; Klaus I Matthaei; Grant R Drummond; Caryl E Hill
Journal:  Pflugers Arch       Date:  2014-06-14       Impact factor: 3.657

6.  Ca(V)3.2 channels and the induction of negative feedback in cerebral arteries.

Authors:  Osama F Harraz; Rasha R Abd El-Rahman; Kamran Bigdely-Shamloo; Sean M Wilson; Suzanne E Brett; Monica Romero; Albert L Gonzales; Scott Earley; Edward J Vigmond; Anders Nygren; Bijoy K Menon; Rania E Mufti; Tim Watson; Yves Starreveld; Tobias Furstenhaupt; Philip R Muellerleile; David T Kurjiaka; Barry D Kyle; Andrew P Braun; Donald G Welsh
Journal:  Circ Res       Date:  2014-08-01       Impact factor: 17.367

Review 7.  Regulation of the T-type Ca(2+) channel Cav3.2 by hydrogen sulfide: emerging controversies concerning the role of H2 S in nociception.

Authors:  Jacobo Elies; Jason L Scragg; John P Boyle; Nikita Gamper; Chris Peers
Journal:  J Physiol       Date:  2016-02-25       Impact factor: 5.182

Review 8.  Potential Benefits of Flavonoids on the Progression of Atherosclerosis by Their Effect on Vascular Smooth Muscle Excitability.

Authors:  Rosa Edith Grijalva-Guiza; Aura Matilde Jiménez-Garduño; Luis Ricardo Hernández
Journal:  Molecules       Date:  2021-06-10       Impact factor: 4.411

9.  Isolated human uterine telocytes: immunocytochemistry and electrophysiology of T-type calcium channels.

Authors:  Sanda Maria Cretoiu; Beatrice Mihaela Radu; Adela Banciu; Daniel Dumitru Banciu; Dragos Cretoiu; Laura Cristina Ceafalan; Laurentiu Mircea Popescu
Journal:  Histochem Cell Biol       Date:  2014-09-12       Impact factor: 4.304

10.  Calmodulin regulates Cav3 T-type channels at their gating brake.

Authors:  Jean Chemin; Valentina Taiakina; Arnaud Monteil; Michael Piazza; Wendy Guan; Robert F Stephens; Ashraf Kitmitto; Zhiping P Pang; Annette C Dolphin; Edward Perez-Reyes; Thorsten Dieckmann; Joseph Guy Guillemette; J David Spafford
Journal:  J Biol Chem       Date:  2017-09-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.